Dyne Therapeutics, Inc. (DYN) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1;…
Source: Yahoo Finance
Sector & Industry
Dyne Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Dyne Therapeutics, Inc. at a Glance
| Company | Dyne Therapeutics, Inc. |
| Ticker | DYN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $24.28 |
| Market cap | $4.53B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$3.26 |
| 52-week high | $27.30 |
| 52-week low | $11.92 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.08 |
| Return on equity (ROE) | -81.57% |
| Debt-to-equity | 33.23% |
| Average volume | 2.23M |
| Shares outstanding | 186.75M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 289 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Dyne Therapeutics, Inc.'s current P/E ratio?
- Dyne Therapeutics, Inc. (DYN) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Dyne Therapeutics, Inc.'s market capitalisation?
- Dyne Therapeutics, Inc.'s market cap is $4.53B based on our latest snapshot. See how it ranks by market cap →
- What is DYN's 52-week range?
- Over the past 52 weeks, DYN has traded between $11.92 and $27.30. What does the 52-week range mean? →
- How volatile is Dyne Therapeutics, Inc. compared to the market?
- Dyne Therapeutics, Inc. has a beta of 1.08, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Dyne Therapeutics, Inc. pay a dividend?
- Dyne Therapeutics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is DYN listed on?
- DYN is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Dyne Therapeutics, Inc. in?
- Dyne Therapeutics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →